Previous 10 | Next 10 |
Opdivo plus Yervoy demonstrates statistically significant and clinically meaningful improvement in overall survival compared to investigator’s choice of sorafenib or lenvatinib Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -9DW trial evaluatin...
2024-03-20 04:50:32 ET Summary Shares of biotechnology companies have been lagging behind the S&P 500 Index. This underperformance of XBI relative to the S&P 500, however, has only made the opportunity even more attractive to us. Evidence of improving fundamentals and ...
2024-03-19 08:19:47 ET More on Fusion Pharmaceuticals Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook Biggest stock movers today: FUSN, NCMI, crypto stocks and more AstraZeneca will buy Fusion Pharmaceuticals for ~$2B Seeking Alpha’s ...
Award-winning actor Ted Danson, who lives with plaque psoriasis, teams up with Bristol Myers Squibb for the inspiring “ SO, Have You Found It? ” campaign. This initiative spotlights the resilience of around two million Americans with moderate to severe plaque psoriasis, aiming t...
2024-03-19 06:46:45 ET Summary Key BMY program revenue is at risk from loss of patent exclusivity over the next several years. The company has turned to acquisitions to fortify its pipeline and revenue streams. BMY is relying on its pipeline of new products and recent acquisit...
2024-03-19 02:19:36 ET Summary Positive safety and anti-tumor activity released from phase 1 portion of phase 1/2a study, using IMM-1-104 for the treatment of patients with RAS-mutant solid tumors. Additional expansion cohort results from the phase 2 portion of the phase 1/2a stud...
2024-03-19 01:45:00 ET Summary Companies are taking advantage of strong investor demand in the investment grade credit market. In just the first two months of 2024, we’ve seen nearly 200 companies issue roughly $380 billion of new bonds in the U.S. investment grade credit p...
2024-03-18 13:49:14 ET Summary Schwab U.S. Dividend Equity ETF™ recently underwent its annual reconstitution, and we see many familiar names. The fund provides exposure to a value-oriented portfolio and has delivered an attractive yield of 3.77% with growth. We've conti...
2024-03-18 12:28:56 ET Summary Schwab U.S. Dividend Equity ETF™ has undergone a major change in its holdings, eliminating and replacing 23 stocks contributing 1/5 of its dividend. Four of the added stocks are flagged as very risky by Seeking Alpha's Quant rating system...
2024-03-18 10:47:01 ET Uber Technologies Inc (UBER) UBER is trading DOWN for the last 4 days, and it at trading at $75.14 with volume of 6,169,515 and a one day change of $-0.93 (-1.22%). Uber Technologies Inc has a 52-week low of 29.22 and a 52-week high of $82.14. The business's 5...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
2024-05-12 04:45:00 ET About once every 90 days, publicly traded companies have to face their shareholders and let them know how their businesses have performed over the past quarter. Those earnings releases often bring with them all sorts of news that can move the market. Sometimes tha...
2024-05-11 07:29:00 ET Bristol Myers Squibb (NYSE: BMY) pays investors an attractive dividend, which yields an incredibly high rate of 5.5%. That's nearly four times the S&P 500 average of 1.4%. At such a high rate, investing approximately $18,200 would be enough to gene...
Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated Opdivo ® (nivolumab) with ...